Description
A sulfatide; levels decrease with age in mice and humans; increased in ASA-KO mouse brain; plasma levels positively correlate with disability progression in patients with relapsing-remitting MS; increased in plasma from patients with MLD
Formal name: N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-octadecanamide
Synonyms: (3′-sulfo)Galβ-Cer(d18:1/18:0)|3′-sulfo Galactosylceramide (d18:1/18:0)|C18 Sulfatide|N-Octadecanoyl Sulfatide
Molecular weight: 808.2
CAS: 244215-65-4
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Neurodegenerative Disorders